CO

CG Oncology

Technology Company

Worked at CG Oncology

MR

Michael Rome

Managing Director & Head of Therapeutics Investing at Foresite Capital

CG Oncology Investors

MR

Michael Rome

Managing Director & Head of Therapeutics Investing at Foresite Capital

SN

Shane Neman

Principal at Neman Ventures

All information is sourced from public domain and might be inaccurate.